Pivot Pharmaceuticals Stock Price, News & Analysis (OTCMKTS:PVOTF)

$1.49 +0.05 (+3.47 %)
(As of 02/25/2018 04:00 PM ET)
Previous Close$1.49
Today's Range$1.38 - $1.68
52-Week Range$0.05 - $2.46
Volume164,256 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Pivot Pharmaceuticals (OTCMKTS:PVOTF)

Pivot Pharmaceuticals Inc., formerly Neurokine Pharmaceuticals Inc., is a development-stage biopharmaceutical company. The Company is engaged in the development and commercialization of therapeutic pharmaceutical products. The Company is in the business of developing and commercializing new uses for existing prescription drugs, as well as developing encapsulation technology in the treatment of neurodegenerative diseases. The Company's research and development activities are focused on advancing drug candidates for the treatment of women's cancers, including, but not limited to metastatic endometrial cancer and triple-negative breast cancer; leveraging drug delivery treatment options to allow targeted delivery of drugs to address women's health needs in urological and/or gynecological indications, and opportunistically in-licensing later-stage drug candidates to augment its drug pipeline.

Receive PVOTF News and Ratings via Email

Sign-up to receive the latest news and ratings for PVOTF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:PVOTF
CUSIPN/A
Phone604-805-7783

Debt

Debt-to-Equity Ratio1.11%
Current Ratio1.93%
Quick Ratio1.93%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value($0.02) per share
Price / Book-74.50

Profitability

Trailing EPSN/A
Net Income$-6,270,000.00
Net MarginsN/A
Return on EquityN/A
Return on Assets-654.40%

Miscellaneous

EmployeesN/A
Outstanding Shares82,220,000

Pivot Pharmaceuticals (OTCMKTS:PVOTF) Frequently Asked Questions

What is Pivot Pharmaceuticals' stock symbol?

Pivot Pharmaceuticals trades on the OTCMKTS under the ticker symbol "PVOTF."

When will Pivot Pharmaceuticals make its next earnings announcement?

Pivot Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Friday, April, 27th 2018. View Earnings Estimates for Pivot Pharmaceuticals.

Who are some of Pivot Pharmaceuticals' key competitors?

Who are Pivot Pharmaceuticals' key executives?

Pivot Pharmaceuticals' management team includes the folowing people:

  • Ahmad Doroudian Ph.D., Chairman of the Board
  • Patrick Frankham Ph.D., Interim Chief Executive Officer, Vice President - Business Development, Director
  • Moira Ong, Chief Financial Officer
  • Wolfgang Renz Ph.D., Director

How do I buy Pivot Pharmaceuticals stock?

Shares of Pivot Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Pivot Pharmaceuticals' stock price today?

One share of Pivot Pharmaceuticals stock can currently be purchased for approximately $1.49.

How can I contact Pivot Pharmaceuticals?

Pivot Pharmaceuticals' mailing address is 1275 WEST 6TH AVENUE, VANCOUVER A1, V6H 1A6. The company can be reached via phone at 604-805-7783.


MarketBeat Community Rating for Pivot Pharmaceuticals (PVOTF)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  19 (Vote Outperform)
Underperform Votes:  17 (Vote Underperform)
Total Votes:  36
MarketBeat's community ratings are surveys of what our community members think about Pivot Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Pivot Pharmaceuticals (OTCMKTS:PVOTF) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Pivot Pharmaceuticals (OTCMKTS:PVOTF) Earnings History and Estimates Chart

Earnings by Quarter for Pivot Pharmaceuticals (OTCMKTS:PVOTF)

Pivot Pharmaceuticals (OTCMKTS PVOTF) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/27/2018        
4/28/2017Q4 2017($0.01)ViewN/AView Earnings Details
12/9/2016Q3 2017($0.01)ViewN/AView Earnings Details
9/12/2016Q2 2017($0.02)ViewN/AView Earnings Details
6/14/2016Q1 2017($0.04)ViewN/AView Earnings Details
4/29/2016Q4 2016($0.05)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Pivot Pharmaceuticals (OTCMKTS:PVOTF) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Pivot Pharmaceuticals (OTCMKTS:PVOTF)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Pivot Pharmaceuticals (OTCMKTS PVOTF)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Pivot Pharmaceuticals (OTCMKTS PVOTF) News Headlines

Source:

SEC Filings

Pivot Pharmaceuticals (OTCMKTS:PVOTF) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Pivot Pharmaceuticals (OTCMKTS PVOTF) Stock Chart for Sunday, February, 25, 2018

Loading chart…

This page was last updated on 2/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.